News

The FDA approved long-acting anticholinergic was indicated for the maintenance treatment of bronchospasm coupled with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. When administered two times

XEN402 is designed to treat pain by targeting sodium channels located at sensory nerve endings. Teva Pharmaceutical Industries president and CEO Dr. Jeremy Levin said, "XEN402 fits this

Theravance leveraged its multivalent approach of drug design to discover the investigational inhaled long-acting muscarinic antagonist TD-4208. Theravance research and early clinical development senior vice president Mathai Mammen

BonyPid is a combined drug and medical device product, which combines bone filler and a substantial antibiotic release platform. The study has shown BonyPid’s positive effect in bone

The patients in the 8 week dose escalation study were treated at dose levels between 0.3 and 12 mg/kg and have also received 5 injections of SM101 during

Acquired assets include Cameo brand of syringe filters, capsule and cut disc filters, transfer membranes besides range of flat sheet and roll stock microporous membranes. Maine will continue

The commencement triggered a $50m milestone to FibroGen from Astellas under a licensing deal signed between the two companies for the inhibitor of hypoxia-inducible factor prolyl hydroxylase. FG-4592/ASP1517

Griseofulvin tablets are antifungal antibiotics which are used to treat ringworm infections of the skin, hair, and nails. Previously, the company has also launched the first generic version

The launch makes all the approved strengths of the reformulated version product including 5mg, 7.5mg, 10mg, 15mg, 20mg, 30mg and 40mg available to patients. Endo Health Solutions chief